Transcription Factor RelA

"Transcription Factor RelA" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A subunit of NF-kappa B that is primarily responsible for its transactivation function. It contains a C-terminal transactivation domain and an N-terminal domain with homology to PROTO-ONCOGENE PROTEINS C-REL.

Descriptor ID	D051996
MeSH Number(s)	D12.776.260.600.249 D12.776.660.600.249 D12.776.930.600.249
Concept/Terms	Transcription Factor RelA Transcription Factor RelA RelA, Transcription Factor NF-kappa B p65 NF kappa B p65 p65, NF-kappa B NF-kappa B p65 Subunit NF kappa B p65 Subunit Transcription Factor p65 p65, Transcription Factor p65 Transcription Factor Transcription Factor, p65 v-Rel Reticuloendotheliosis Viral Oncogene Homolog A v Rel Reticuloendotheliosis Viral Oncogene Homolog A NF-kappaB 65-kDa NF kappaB 65 kDa

Below are MeSH descriptors whose meaning is more general than "Transcription Factor RelA".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
DNA-Binding Proteins [D12.776.260]
NF-kappa B [D12.776.260.600]
Transcription Factor RelA [D12.776.260.600.249]
Nuclear Proteins [D12.776.660]
NF-kappa B [D12.776.660.600]
Transcription Factor RelA [D12.776.660.600.249]
Transcription Factors [D12.776.930]
NF-kappa B [D12.776.930.600]
Transcription Factor RelA [D12.776.930.600.249]

Below are MeSH descriptors whose meaning is related to "Transcription Factor RelA".

Below are MeSH descriptors whose meaning is more specific than "Transcription Factor RelA".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Transcription Factor RelA" by people in this website by year, and whether "Transcription Factor RelA" was a major or minor topic of these publications.

Bar chart showing 39 publications over 18 distinct years, with a maximum of 5 publications in 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	0	1	1
2000	0	3	3
2002	0	1	1
2003	0	1	1
2004	0	2	2
2005	0	2	2
2006	1	0	1
2007	2	3	5
2008	0	2	2
2009	3	0	3
2010	2	1	3
2011	1	2	3
2012	1	1	2
2013	1	1	2
2014	1	1	2
2017	1	1	2
2019	1	1	2
2020	1	1	2

Below are the most recent publications written about "Transcription Factor RelA" by people in Profiles.

Tateishi K, Miyake Y, Kawazu M, Sasaki N, Nakamura T, Sasame J, Yoshii Y, Ueno T, Miyake A, Watanabe J, Matsushita Y, Shiba N, Udaka N, Ohki K, Fink AL, Tummala SS, Natsumeda M, Ikegaya N, Nishi M, Ohtake M, Miyazaki R, Suenaga J, Murata H, Aoki I, Miller JJ, Fujii Y, Ryo A, Yamanaka S, Mano H, Cahill DP, Wakimoto H, Chi AS, Batchelor TT, Nagane M, Ichimura K, Yamamoto T. A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma. Cancer Res. 2020 12 01; 80(23):5330-5343.

View in: PubMed
Henkel M, Partyka J, Gregory AD, Forno E, Cho MH, Eddens T, Tout AR, Salamacha N, Horne W, Rao KS, Wu Y, Alcorn JF, Kostka D, Hirsch R, Celedón JC, Shapiro SD, Kolls JK, Campfield BT. FSTL-1 Attenuation Causes Spontaneous Smoke-Resistant Pulmonary Emphysema. Am J Respir Crit Care Med. 2020 04 15; 201(8):934-945.

View in: PubMed
Sun F, Li L, Yan P, Zhou J, Shapiro SD, Xiao G, Qu Z. Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance. Nat Commun. 2019 11 22; 10(1):5324.

View in: PubMed
Feldman D, Singh A, Schmid-Burgk JL, Carlson RJ, Mezger A, Garrity AJ, Zhang F, Blainey PC. Optical Pooled Screens in Human Cells. Cell. 2019 10 17; 179(3):787-799.e17.

View in: PubMed
Hung SC, Huang PR, Almeida-da-Silva CLC, Atanasova KR, Yilmaz O, Ojcius DM. NLRX1 modulates differentially NLRP3 inflammasome activation and NF-?B signaling during Fusobacterium nucleatum infection. Microbes Infect. 2018 Oct - Nov; 20(9-10):615-625.

View in: PubMed
Victor AR, Nalin AP, Dong W, McClory S, Wei M, Mao C, Kladney RD, Youssef Y, Chan WK, Briercheck EL, Hughes T, Scoville SD, Pitarresi JR, Chen C, Manz S, Wu LC, Zhang J, Ostrowski MC, Freud AG, Leone GW, Caligiuri MA, Yu J. IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-?B. J Immunol. 2017 10 01; 199(7):2333-2342.

View in: PubMed
Cachia D, Wani K, Penas-Prado M, Olar A, McCutcheon IE, Benjamin RS, Armstrong TS, Gilbert MR, Aldape KD. C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma. Brain Tumor Pathol. 2015 Apr; 32(2):105-11.

View in: PubMed
Lennard Richard ML, Nowling TK, Brandon D, Watson DK, Zhang XK. Fli-1 controls transcription from the MCP-1 gene promoter, which may provide a novel mechanism for chemokine and cytokine activation. Mol Immunol. 2015 Feb; 63(2):566-73.

View in: PubMed
Shintaku J, Guttridge DC. Reining in nuclear factor-kappaB in skeletal muscle disorders. Curr Opin Clin Nutr Metab Care. 2013 May; 16(3):251-7.

View in: PubMed
Deng X, Xu M, Yuan C, Yin L, Chen X, Zhou X, Li G, Fu Y, Feghali-Bostwick CA, Pang L. Transcriptional regulation of increased CCL2 expression in pulmonary fibrosis involves nuclear factor-?B and activator protein-1. Int J Biochem Cell Biol. 2013 Jul; 45(7):1366-76.

View in: PubMed

People

Explore

Similar Concepts

Top Journals